Document is current
Any future updates will be listed below
-
Authors
Lahusen, Anton
Lutz, Manfred P.
Fang, Rui
Kirchner, Martina
Albus, Sarah
Kluck, Klaus
Karthaus, Meinolf
Schwarzer, Andreas
Siegler, Gabriele
Kleger, Alexander
Ettrich, Thomas J.
Becher, Alexander
Höfling, Sabine
Siveke, Jens T.
Budczies, Jan
Tannapfel, Andrea
Stenzinger, Albrecht
Cheung, Phyllis Fung-Yi
Eiseler, Tim
Seufferlein, Thomas
-
Funding
Funding for this research was provided by:
Servier Deutschland GmbH (PREDICT)
Institutional funding of the Department of Internal Medicine I
Universitätsklinikum Ulm
- License Information
-
More Information
Article History
Received: 9 May 2025
Accepted: 9 July 2025
First Online: 22 July 2025
Declarations
:
: The PREDICT trial was conducted in accordance with the Declaration of Helsinki. An independent ethics committee (Ethics Committee of the Medical Association of Saarland, Faktoreistraße 4, 66111 Saarbrücken) reviewed the study and all amendments with ethics approval number 211/17. Written informed consent, including participation in translational research, was obtained from each patient before any study-specific medical procedure was performed.Liquid biopsy samples were collected upon informed consent including participation in translational research and stored in the Internal Medicine I Liquid Biopsy Biobank at the University Hospital Ulm, in accordance with ethics approval 67/19 (Ethics Committee of the University of Ulm, Helmholtzstraße 20, 89081 Ulm). The cited local ethics approval 67/19 covers secondary use of biobank samples. We only used patients that had given their written full consent for the use of biomaterials.
: Not applicable.
: The authors declare no competing interests.
